The function of the majority of genes in the mouse and human genomes remains unknown. The mouse embryonic stem cell knockout resource provides a basis for the characterization of relationships between genes and phenotypes. The EUMODIC consortium developed and validated robust methodologies for the broad-based phenotyping of knockouts through a pipeline comprising 20 disease-oriented platforms. We developed new statistical methods for pipeline design and data analysis aimed at detecting reproducible phenotypes with high power. We acquired phenotype data from 449 mutant alleles, representing 320 unique genes, of which half had no previous functional annotation. We captured data from over 27,000 mice, finding that 83% of the mutant lines are phenodeviant, with 65% demonstrating pleiotropy. Surprisingly, we found significant differences in phenotype annotation according to zygosity. New phenotypes were uncovered for many genes with previously unknown function, providing a powerful basis for hypothesis generation and further investigation in diverse systems.
(EMPReSS) database 10 catalogs the standard operating procedures (SOPs) that were developed, including operational details and the parameters measured. More recently, a major single-center effort to analyze several hundred knockout lines through a phenotyping pipeline has illuminated the pleiotropy that can be found and the opportunities to uncover new gene functions 7 .
The EMPReSS SOPs are the foundation for future large-scale phenotyping efforts, and the European Mouse Disease Clinic (EUMODIC) consortium has used a subset of these procedures to undertake a multicenter, broad-based phenotyping effort to characterize the phenotypes of 449 mutant mouse alleles. We report the application of statistical approaches to the development of an experimental design that maximizes power to detect abnormal phenotypes. We apply new Bayesian statistical methodologies for analysis of the phenotype data acquired, with the aim of controlling the false discovery rate (FDR) and providing robust data on abnormal phenotypes at high confidence.
In summary, we have developed both experimental and statistical approaches for high-throughput, broad-based phenotyping and report here our first multicenter effort to catalog and analyze the phenotypes for 320 mouse genes. These approaches identify extensive pleiotropy, along with a high discovery rate of abnormal phenotypes for genes with no previous annotation of function. Moreover, for a number of lines, we were able to compare phenotype annotations for homozygotes and heterozygotes, identifying significant differences in phenotype annotation according to zygosity.
RESULTS

The phenotyping pipeline
We have employed the EMPReSSslim pipeline for high-throughput phenotyping analysis, which was developed under the EUMORPHIA program 9 and incorporates a standardized and validated set of tests Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics A full list of authors and affiliations appears at the end of the paper. Phenotypic annotations of knockout mutants have been generated for about a third of the genes in the mouse genome 1 . However, the way in which the phenotype is screened is often dependent on the expertise and interests of the investigator, and in only a few cases has a broad-based assessment of phenotype been undertaken that encompassed the analysis of developmental, biochemical, physiological and organ systems [2] [3] [4] . Assessing and cataloguing pleiotropy 5 will be critical in beginning to understand the contribution of each gene to metabolic pathways, physiological and organ systems, and disease states and to interpret the effects of these contributions on health and disease. Notably, an understanding of the role of loci identified in human genetics studies will be underpinned by phenotypic analyses in the mouse, which will inform further studies of genetic and physiological systems in humans. Thus, systematic efforts to undertake broad-based phenotyping of mouse mutants and inbred strains 6, 7 will be of great value to understanding the genetic basis for phenotype and disease states.
It is recognized that any large-scale analysis of mammalian gene function by phenotyping of mouse mutants will require a number of important advances in phenotyping approaches and the scientific infrastructure to deliver large-scale robust data sets together with the development of data acquisition, analysis and display tools 2, 3, 8 . The delivery of a comprehensive functional annotation of mouse genes is beyond the infrastructure and capacity of a single center, and a multicenter approach will be required. It is therefore vital to develop a phenotyping pipeline that has been validated across multiple centers and is robust to differences in time and place. The EUMORPHIA (European Union Mouse Research for Public Health and Industrial Applications) program reported the development of a set of robust phenotyping tests 9 that was validated across our consortium and has subsequently been used in a variety of phenotyping projects.
The European Mouse Phenotyping Resource of Standardised Screens
A r t i c l e s npg A r t i c l e s underpinned by SOPs 10 . EMPReSSslim (Supplementary Fig. 1 ) comprises two component pipelines each incorporating different tests, with a separate cohort of mice analyzed in each pipeline. EMPReSSslim encompasses 20 phenotyping tests, capturing 413 parameters. The phenotyping tests chosen cover a variety of diseaserelated and biological systems, including the metabolic, cardiovascular, bone, neurological and behavioral, sensory and hematological systems and clinical chemistry.
A statistical power analysis was performed to quantify the standardized effect size for the mutant genotype, d, that would be detectable under a variety of experimental workflows and analysis methods, where d = − | | / b b s mutant geno baseline geno , the absolute difference between the mutant and baseline mean values scaled in units of the phenotypic standard deviation; calculations were based on attaining 80% power under a frequentist linear model with correlated observations (resulting from effects from day of analysis and litter) at a significance level of 1 × 10 −7 estimated to control the FDR at 5% ( Fig. 1a, Supplementary Figs. 2 and 3, and Supplementary Note) . This analysis demonstrated that considerable power is to be gained, first, by including, as was the practice in EUMODIC, the entire set of baseline data (for control C57BL/6N wild-type mice) in the analysis and, second, by phenotyping baseline mice on the same days as mutants, which was achieved for approximately 71% of the data. Given that these two conditions are met, there is little difference in detectable effect size between phenotyping mutants assessed on a single day (the case for 32% of the lines) or across multiple days (the case for 68% of the lines).
In EUMODIC, we used a cohort sample size of 14, consisting of 7 males and 7 females. Under the most powerful design-analysis combination in Figure 1a , increasing the sample size from 14 to 20 mice would decrease the detectable d value from 1.64 to 1.39 (a 15% improvement), whereas decreasing the sample size from 14 to 8 mice would increase d from 1.64 to 2.14 (a 31% increase), illustrating that only a relatively small decrease in detectable effect size would be attained by increasing the sample size above 14. In establishing a minimum target number of baseline mice, we propose analysis over at least 50 d with mice from two or more litters represented on each day, as this approach provides relatively precise estimation of variance components in the multilevel model ( Supplementary Fig. 3 ). In power calculations, a reduction in the number of days over which baseline mice were analyzed from 100 to 50 only increased the estimated detectable d value from 1.64 to 1.68 (a 3% increase).
Generation of mouse mutants and assessment of viability and fertility
Embryonic stem (ES) cell lines from the European Conditional Mouse Mutagenesis Program (EUCOMM) resource were injected to generate chimeras 11 . Following the recovery of germline-transmitting progeny, for the majority of lines, heterozygotes were intercrossed to generate homozygous mutants. Of the lines analyzed (303), 187 heterozygotes were intercrossed and assessed for homozygous viability. Where we failed to recover homozygotes from heterozygote intercrosses in sufficient numbers, we classified the mutation as either embryonic lethal (no homozygotes recovered from 28 progeny) or subviable (≤13% of 28 progeny). We found that, in total, 65 lines (34.8%) had homozygous mutants that were embryonic lethal and 22 lines (11.8%) had homozygous mutants that were subviable. Four lines (2.1%) showed a reduced lifespan (defined as death after weaning and before the end of a normal lifespan). Where homozygotes were embryonic lethal or subviable, we analyzed heterozygotes through EMPReSSslim. For many of the viable homozygote lines, we also assessed fertility. Of the 153 lines investigated, we found that 2.6% (4/153) showed reduced fertility, including 1 line with reduced fertility in both males and females, 1 line with reduced fertility in females and 2 lines with The two qualitative design choices under consideration were (i) whether mutant mice were phenotyped across multiple days with four mice assessed per day or all mice were phenotyped on a single day and (ii) whether baseline mice were phenotyped on the same day(s) as mutants (that is, whether the mutants were 'accompanied'). Two analytical approaches were compared: (i) analysis of all baseline data (all data) and (ii) analysis restricted to baseline data from mice phenotyped on the same day(s) as mutants (accompanied data only). Calculations were based on attaining 80% power while controlling the FDR at 5%. The variance components used in the power calculations were taken as the average estimates across all parameters and procedures: the variance proportion was 0.18 for effect from day of analysis, 0.12 for litter effects and 0.69 for residual effects (supplementary Fig. 2 shows similar plots for procedure-specific variance components). (b) Histogram of the number of annotations per line, with each bar split into counts arising from homozygous and heterozygous lines. (c) Histogram of the number of annotations within each top-level MP ontology term, with each bar split into numbers arising from mutant lines with or without annotations in MGI.
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A r t i c l e s reduced fertility in males. To test the applicability of the new methods, we also analyzed a number of additional mutant lines, including ones with N-ethyl-N-nitrosourea (ENU)-generated and other targeted mutations and gene traps. In many cases, these lines were analyzed as heterozygotes and the appropriate background strain was used as a wild-type control (Online Methods).
Phenotype data acquisition and analysis
Data from mutants and controls analyzed through EMPReSSslim were captured in the EuroPhenome database 12 . In addition, the data have been incorporated into the International Mouse Phenotyping Consortium (IMPC) portal 13 . We have developed and implemented statistical models incorporating a broad range of characteristics common to high-throughput mouse phenotyping data, such as non-Gaussian response distributions, complex correlation structure, confounding variables, systematic drift in measurements over time, outliers and other data anomalies ( Fig. 1 , Online Methods and Supplementary Note).
Phenotyping variance
We explored the potential for differences in phenotyping variance across centers in C57BL/6N control mice by estimating the variance components underlying each transformed quantitative parameter ( Fig. 2 and Supplementary Fig. 1 ). The total phenotyping variance differed considerably across centers for some parameters, but this variation can only be viewed as a potential indication of more or less precise experimental measurement, due to differences in equipment and, hence, measurement scale across centers. To examine scale-free measures of variation, we estimated the proportion of phenotyping variance attributable to day of analysis, litter and residual effects, with average proportions across all parameters of 18%, 12% and 69%, respectively. Of the three variance proportions, those for litter and residual effects were composed substantially of biological variation between litters and animals. In contrast, the variance proportion due to day of analysis was mainly driven by unmodeled experimental variation and can therefore indicate where experimental procedures could potentially be improved. The variance 0 0.5 
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A r t i c l e s proportion due to day of analysis was on occasion systematically higher at a particular center-for example, in the analysis of some calorimetry parameters at Institut Clinique de la Souris (ICS), some open-field parameters at MRC-Harwell and some acoustic startle parameters at Helmholtz Zentrum München (HMGU)-with the corresponding variance proportions typically reflecting a day's worth of outlying baseline data. For some procedures, the variance proportion due to day of analysis was generally smaller at some centers than at others, potentially reflecting more consistent experimental protocols at those centers. Reflecting the between-center differences Figure 3 Heat map comparing the annotations of reference lines across centers. Colors represent scaled genotype effect (posterior median/standard deviation), with blue or red indicating a mutant phenotype with decreased or increased strength relative to baseline mice, respectively. Significant annotations (FDR < 5%) are indicated by a black outline around the corresponding cell. WTSI, Wellcome Trust Sanger Institute. npg A r t i c l e s in variance observed, data analyses were restricted to within-center comparisons between controls and mutants.
Most notably, EUMODIC analyzed a large set of 22 common reference mutant lines across the multiple centers to examine the between-center reproducibility of the phenotyping tests ( Fig. 3) . For each line phenotyped at two or more centers, we compared estimates of the genotype effect across centers for each parameter, both visually ( Fig. 3 and Supplementary Figs. 4 and 5 ) and using two meta-analytical measures of heterogeneity Q and I 2 (ref. 14) . The lines were found to exhibit high levels of between-center phenotypic heterogeneity in approximately 9% of comparisons (using the threshold I 2 > 0.75) and statistically significant heterogeneity in 7% of comparisons (Cochran's Q test at FDR < 5%). Sixty-two percent of cases were estimated to have no heterogeneity (I 2 = 0); thus, although there was considerable discordance in about 8% of comparisons, between-center consistency was observed in the majority of instances. Relatively extreme phenotypic perturbations, demonstrated by, for example, Mysm1, were reproducibly annotated across two or more centers, whereas a number of gene effect sizes were weaker and less reproducibly detected across centers ( Fig. 3 and Supplementary Fig. 4) , consistent with there being reduced power to detect smaller effects. Indeed, of the 183 lines that were annotated in at least one of the centers, 61 (33%) were annotated concordantly in more than one center. However, when effect estimates were compared for pairs of centers where a call was made in one center but not the other, 158 of 222 cases (71%; exact binomial one-tailed P = 1.2 × 10 -10 ) displayed estimates of genotype effect in the same direction (Supplementary Fig. 5) . Overall, the data from the reference lines highlight the concordance of the data between centers while emphasizing the possibility of false negative results.
Phenotype annotations from 449 mutant lines
Thus far, we have phenotyped 449 mutant mouse alleles and accumulated phenotype data on 27,707 mice. In total, we generated 9,019,984 data points and ascribed 2,947 phenotype annotations to 320 genes. The global representation of significant and nonsignificant phenotypes in Figure 4 enables the visualization of consistent trends in significant hits across centers. In addition, this global heat map highlights a number of lines with multiple hits across tests (for example, acoustic startle and open field) and within a single test (for example, dual-energy X-ray absorptiometry (DEXA)), as would be expected from a test measuring different aspects of the same phenotype. Moreover, it is apparent from the heat map that broad phenotypic effects are often but not always associated with a body weight phenotype.
We identified 2,316 non-body weight parameter annotations at an estimated annotation FDR of 2.2%. We found that 374 of the 449 mutant alleles representing 320 genes (83%) had at least one parameter annotation, at an estimated FDR per line of 11%. Multiple testing across several hundred parameters in a line causes the FDR for that line (11%) to be greater than the annotation FDR (2.2%). We found that 133 of 448 lines (30%) had at least one body weight parameter annotated, at an estimated FDR for the line of 5%. Sixty-five percent of lines (290/449) had more than one phenotypic hit. Overall, pleiotropy was effectively demonstrated with the pipelines used. 
Genotype effect Figure 4 Heat map of annotations for the complete data set. Colors represent scaled genotype effect (posterior median/standard deviation), with blue or red indicating a mutant phenotype with decreased or increased strength relative to baseline mice, respectively. Significant annotations (FDR < 5%) are indicated by a black outline around the corresponding cell. Labels for non-EUCOMM lines are in red. For legibility, the heat map only displays a subset of parameters for the lines with at least three annotations.
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We also analyzed annotation hit rates according to zygosity. The proportion of lines with at least one annotation was higher for homozygotes at 88% (219 of 248 mutant lines tested) than for heterozygotes at 77% (151 of 197 lines tested), with this difference statistically significant (χ 2 test, P = 0.002) (Fig. 1b) . The mean number of annotations was 8.3 (s.e.m. = 0.8) for homozygotes, significantly higher than the 4.4 annotations (s.e.m. = 0.5) for heterozygotes (negative binomial generalized linear model (GLM), Wald test, P = 6 × 10 -7 ). Nevertheless, the high annotation hit rate for heterozygotes underscores the usefulness of phenotyping heterozygotes and adds to the catalog of dosage-sensitive genes.
Finally, we assessed the performance of each individual phenotyping test by computing the hit rate for each procedure ( Supplementary  Fig. 6 ). First, as expected, the overall hit rates across tests showed considerable variation, ranging from higher rates for clinical chemistry (33%) and body weight (29%) testing to lower rates for hot-plate (4%) and heart weight/tibia length ratio (3%) testing. The distribution of phenotype outputs was similarly reflected in the number of annotations per top-level Mammalian Phenotype (MP) ontology term (Fig. 1c) . Second, there were significant differences in hit rates across centers for 13 of the 20 tests (Fisher's exact test controlling FDR ≤ 5%), with the tendency for hit rates to be relatively high at MRC-Harwell and the Wellcome Trust Sanger Institute and lower at ICS (Supplementary Fig. 6 ). Variation in hit rates across centers is unsurprising given that a subset of mutant lines, mainly non-EUCOMM lines, was selected on the basis of preexisting phenotypic information at some centers. Phenotypically selected lines are more likely to have broad-effect phenotypes, particularly when pleiotropy is taken into account. The effect of gene choice is illustrated in Figure 4 , where a relatively small number of lines, preferentially non-EUCOMM lines (in red), contributed strongly to the annotation sets at MRC-Harwell and the Wellcome Trust Sanger Institute and to a lesser extent to the HMGU annotation sets. At ICS, however, where non-EUCOMM lines were selected at random with respect to phenotype, there was a lower annotation rate ( Fig. 4 and Supplementary  Table 1 ). Although we attribute the observed differences mainly to effects from gene choice, we investigated the alternative explanation that differences in phenotyping across centers could lead to variation in power and thus the annotation hit rate ( Fig. 2 and Supplementary  Data Set) . Differences in sample size, unmodeled variation in baseline mice and heterogeneity in phenotyping variance (particularly the variance proportion due to the day of analysis) explained the variation in hit rate for a few particular parameters, but the extent of these effects was minor relative to the global impact of gene choice.
Homozygote and heterozygote comparisons
For 43 of the mutant genes, we analyzed both homozygotes and heterozygotes to compare phenotype outputs according to zygosity. The heterozygotes accumulated 101 parameter annotations in comparison to 410 parameter annotations for the homozygotes. We found 53 annotations in common between heterozygotes and homozygotes, which were confined to 11 of the 43 lines. Interestingly, we found that effect sizes for parameters that were identified in both homozygotes and heterozygotes tended to be stronger in homozygotes (Supplementary Fig. 7) .
Phenotype similarity to published data sets
We assessed the similarity between the phenotypes for the EUMODIC data set and those observed for genes in the Mouse Genome Informatics (MGI) database 1 . We investigated the ability to classify EUMODIC-MGI gene pairs as matched or unmatched on the basis of phenotype similarity ( Fig. 5) and found the phenotypes observed in EUMODIC to be significantly more similar to the MGI literature-curated phenotypes for alleles of the same gene than they were to phenotypes for alleles of different genes (P = 0.00048; Online Methods).
New gene function identified
Aside from genes with existing phenotype annotations, we analyzed a large class of genes with no previous annotations (Online Methods). Around half of the genes analyzed (179) had no previous annotations in the MGI curated database. We found that for 87.9% (152/179) of the genes in this class we were able to identify perturbed phenotypes. This discovery rate is similar to the overall discovery rate for all mutants in the EMPReSSslim pipeline, demonstrating that the pipeline is efficient at uncovering phenotypes in mutants with phenotype-poor as well as phenotype-rich annotations.
For the class of genes with no previous annotations, we have undertaken an analysis to determine whether the new mouse models can provide knowledge about the functional role of human genome-wide association study (GWAS)-discovered loci, genes associated with rare diseases and genes associated with human genetic disorders in Online Mendelian Inheritance in Man (OMIM) 15 . Of the 152 genes with significant phenotypes identified by EUMODIC, 21 were orthologs for genes associated with rare diseases in Orphanet 16 , 20 were orthologs for genes involved in genetic disorders in OMIM and 36 were orthologs of genes associated with GWAS loci (Online Methods). We investigated whether the phenotype data from the mice showed concordance with the human disease data (Online Methods). Of the 42 unique genes associated with disease in humans, 14 showed a phenotypic correlation with the mouse gene (Supplementary Table 2) , demonstrating that the new mouse models recapitulate phenotypes that correlate with human disease and, in a number of cases, add functional data for known human diseases. In addition, this correlation demonstrates that mouse models are a valuable resource for studying the role of genes of unknown function.
To further investigate the role of the previously uncharacterized genes in disease, we examined three disease areas, including (i) metabolic disorders, comprising diabetes and obesity, (ii) bone and skeleton disorders, and (iii) neurological and behavioral disorders, to determine 
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Sixty-nine genes exhibited effects on metabolic parameters, identifying a number of new metabolic loci. For example, mice with mutant Elmod1, a gene with no existing functional information, showed reduced fasted blood glucose concentration and area under the glucose response curve, reduced concentrations of various blood lipids and reduced body weight.
Classification of genes according to bone and skeletal parameters identified 39 genes, including the solute carrier Slc38a10, which has already been reported as an interesting candidate gene for bone disease 17 . Our analysis of the EUMODIC data set annotated Slc38a10 in the domain corresponding to neurological and behavioral disorders, providing a typical example of the pleiotropy that is observed by using the phenotyping pipeline. Of the 45 genes in the neurological and behavioral domain, we identified many candidate disease-associated genes. Interestingly, the mouse knockout of Elmod1 showed increased activity (as measured in open-field and SHIRPA (SmithKline Beecham, Harwell, Imperial College, Royal London Hospital, phenotype assessment) analyses), a lack of fluidity in gait and increased frequency of trunk curling, reduced grip strength, reduced acoustic startle response in one amplitude and reduced prepulse inhibition across multiple amplitudes.
DISCUSSION
We have demonstrated the feasibility of multicenter, large-scale, broad-based phenotyping of mutant mouse lines for the generation of rich new phenotypic information. There were a number of new experimental and statistical developments that were required to undertake a multicenter approach to the large-scale phenotyping of mouse mutants.
First, a multicenter approach requires the use of robust, validated phenotyping tests, and EUMODIC employed the EMPReSS procedures in a common phenotyping pipeline, EMPReSSslim. In using these procedures, we undertook a statistical power analysis of the experimental design to determine the impact on the effect size of mutant genotypes under a variety of experimental workflows and analysis methods. This analysis underscored the usefulness of whether significant phenotype hits in mice can either singly or in combination indicate a potential disease model. In each case, we identified combinations of tests where a phenotype hit would be indicative of the relevant disease correlate. Subsequently, we analyzed our set of genes with no previous annotations for phenotype hits in each test class and plotted each gene with one or more hits in a Venn diagram (Fig. 6) . Our expectation is that genes with multiple hits represent interesting candidates for further exploration and validation. For each disease area, we have identified a large number of interesting candidate disease-associated genes, several of which had effects on diverse disease areas. npg A r t i c l e s employing the entire control baseline set and the phenotyping of baseline mice on the same day as mutants. This analysis also indicated that reasonable power was provided by a cohort sample size of 14, with only modest power enhancements if the cohort size was increased. Nevertheless, increased power would potentially enhance betweencenter reproducibility.
Second, we developed and implemented new statistical models that addressed many of the features of large-scale, multivariate mouse phenotyping data sets, aiming to ensure the reproducibility of phenotype calls via permutation-based control of the FDR. In carrying out this analysis, we examined the phenotyping variance attributable to day of analysis, litter and residual effects. Whereas litter and residual effects reflect the biological variation between litters and animals, the variation due to day of analysis reflects experimental variation and was higher or lower for some tests at some centers. These analyses allow the consideration of unwanted variation underlying the reproducibility of phenotyping protocols and feed forward into test improvements in the future.
Third, we employed 22 reference lines to directly test between-center reproducibility. We found high levels of between-center phenotypic heterogeneity in only 9% of comparisons, whereas, in contrast, for 62% of parameters no heterogeneity was observed. These results indicate a high level of concordance for phenotyping tests across centers.
The analysis of the EUMODIC data set identified a significant number of pleiotropic lines, with 65% (290/449) having more than one phenotype annotation. A large number of lines (30% at an FDR of 5%) had at least one body weight parameter annotated, and it is noteworthy that there is strong association between non-body weight annotations and annotations to body weight parameters (Fig. 4) . Thus, body weight is a potential early marker for pleiotropic phenotypic effects.
Intriguingly, we found a high phenotype hit rate for heterozygotes (77%), although the hit rates for homozygotes were significantly higher than those for heterozygotes. Thus, analysis of heterozygotes further enriches the data set and provides information on dosagesensitive loci and their phenotypic effects. In this regard, comparisons of the 43 lines where both homozygotes and heterozygotes were analyzed showed that, although a considerable number of annotations are shared, a number of annotations are unexpectedly specific to heterozygotes. These data imply significant differences in pathway outcomes from the loss of a single copy versus two copies of each gene, and these dosage-sensitive annotations will merit further investigation. Such studies will potentially have a bearing on wider understanding of haploinsufficiency and its contribution to disease in the human population 18 . The phenotype hit rates for genes without any previous annotation underline the value of the broad-based phenotyping and analysis methodologies that we developed. We extended the analysis of this class of genes, aiming to identify new candidate disease-associated genes. For three disease areas (metabolism, bone and skeleton, and neurological and behavior disorders), we identified parameter sets among which hits would be indicative of the relevant disease correlate and assigned genes with appropriate annotations to the different disease areas. We identified a large number of genes (94) with single or multiple hits across the parameter sets. Some genes were exclusive to an individual disease area, whereas others had hits in multiple disease areas, reflecting the underlying pleiotropy identified by the program.
Notably, we uncovered new candidate disease-associated genes that merit further investigation. One such gene, Elmod1, belongs to the large class of genes expressed in the brain for which there is little if any functional information (the so-called 'ignorome'; ref. 19) . Many of these genes are indistinguishable from well-studied genes in terms of network connectivity and other protein characteristics. Elmod1 has recently been shown to be involved in auditory function 20 , but no other functional attributes have been determined. However, Elmod1 is associated with a strong cis expression quantitative trait locus (eQTL) for brain expression, including regional brain expression. Moreover, variation in locomotor activity is known to map in the region of the Elmod1 locus on chromosome 9. Using the EUMODIC pipeline, we have been able to demonstrate the function of Elmod1 in several behavioral traits. Notably, we have also shown that the Elmod1 mutant displays a number of metabolic traits, further elaborating the functional characterization of this largely unexplored locus. This analysis underscores the diversity of hypotheses that might be generated from the development of a genome-wide data set.
In summary, the work described here demonstrates the usefulness of scaling phenotyping efforts from hundreds to thousands of mouse mutants as the international mouse genetics community embarks on the comprehensive annotation of all the protein-coding genes in the mouse genome 8 . Most notably, it provides fundamental insights into the experimental design and statistical analyses that will underpin large multicenter programs to gather and analyze robust phenotype data. As such, the work reported here paves the way toward a reference resource with a well-defined series of mutant alleles and a broadbased phenotyping data set accessible to the scientific community for further in-depth characterization. 
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ONLINE METHODS
Mouse generation.
Targeted ES cell clones obtained from the EUCOMM cell repository (EuMMCR) were injected into BALB/cAnN or C57BL/6J blastocysts for chimera generation. The resulting chimeras were mated to C57BL/6NTac mice, and the progeny were screened to confirm germline transmission. As part of the original targeting strategy, the ES cell clones were derived from one of four different C57BL/6N parental cell lines, namely JM8.F6, JM8.N4, JM8A3.N1 and JM8A1.N3. The JM8A3.N1 and JM8A1.N3 cell lines had been subjected to targeted repair to correct the non-agouti allele 21 .
Mice carrying targeted mutations were bred to C57BL/6NTac mice before the intercrossing of heterozygote carriers. Cohorts of at least seven homozygote mice of each sex per pipeline were generated by the most effective breeding scheme, depending on the mutant line and the mice available. If no homozygotes were obtained from 28 or more offspring of heterozygote intercrosses, the line was deemed nonviable. Similarly, if less than 13% of the pups resulting from intercrossing were homozygous, the line was judged as being subviable. In both circumstances, heterozygote mice were committed to the phenotyping pipelines. The fertility of both sexes of each line was also assessed during cohort generation. Mutant lines failing to produce any live pups when at least four homozygotes of either sex were mated with a non-homozygote mouse were assessed as sub-fertile. Phenotype cohorts were obtained from sub-fertile lines by breeding heterozygotes of the affected sex.
As both wild-type and mutant cohorts were analyzed through the phenotyping pipeline, randomization in the allocation of mice to experimental groups was not relevant. Although randomization was not employed, there was no preferential selection of stock, either mutant or wild type, for phenotyping. Reflecting the high-throughput nature of the phenotyping pipeline, blinding to the identity of mutant lines during phenotyping was not employed. However, assessment of the effect of operator bias was a quality control step that was performed during data analysis.
The targeted alleles were validated by conventional PCR for the presence of the 3′ loxP site and by non-radioactive Southern blot with neo or lacZ probes for the accuracy of homologous recombination events. Whenever sequences permitted, two different enzymes were employed for each arm. A number of other existing mutant lines, including ones with ENU-generated mutations, other targeted alleles and gene traps, were bred and analyzed through the EMPReSSslim pipeline. In total, mice were bred from 449 lines for phenotyping, of which 334 were EUCOMM lines. The total numbers generated and analyzed at each center were as follows: HMGU, 101; MRC-Harwell, 141; Wellcome Trust Sanger Institute, 72; and ICS, 136. In addition, 13 lines were analyzed through EMPReSSslim at TCP.
EUMODIC institutes that collect phenotyping data are guided by their own ethical review panels and licensing and accrediting bodies, reflecting the national legislation under which they operate. Details of their ethical review bodies and licenses are provided below. All efforts were made to minimize suffering by considerate housing and husbandry. All phenotyping procedures were examined for potential refinements that were disseminated throughout the consortium. Data capture by EuroPhenome. The EMPReSS database 10 incorporates SOPs, measured data parameters and metadata from the EMPReSSlim pipelines. In addition, EMPReSS stores the MP ontology annotations for the majority of parameters, that is, the expected phenotype that would be identified if the mutant were statistically different from the control. All of the data in EMPReSS have now been migrated to the newer international version of the database called IMPReSS, which holds all of the IMPC standardized phenotyping protocols. Further details on the implementation of the ARRIVE guidelines in EUMODIC and IMPC are described in Karp et al. 22 . Data generated from EMPReSSlim by the four centers are stored in their local LIMS, backed by diverse database schemas running on different relational database management systems. The collection of phenotyping data at each center was guided by that center's ethical review panel and licenses applicable to each county's regulations. The data are transferred to EuroPhenome in a common standardized format. To assist in data export and improve standardization and data consistency, EuroPhenome provides a java library for data export. The informaticians at the centers use the library to represent the data to be exported as an object model. The library then performs the necessary validation against the EMPReSS database and the schema. If this validation is successful, the data are output to XML, compressed and placed on an FTP site.
Each center's FTP site is regularly checked by the EuroPhenome data capture system, and any new files are uploaded. The data are again verified against the schema and EMPReSS and are further checked for consistency against existing data within EuroPhenome. The results of the upload and validation are provided to the sites in the form of XML log files and a web interface, the EuroPhenome Tracker. If validation is successful, the data are loaded into the EuroPhenome database. Data can be removed from the database by placing the files in the delete directory of the FTP site. The same process is employed to capture and validate the data before removal. The informatics architecture that supported EUMODIC has now been enhanced to support the larger IMPC project.
Statistical analysis.
Bayesian linear and logistic multilevel regression models were applied to each transformed quantitative or dichotomized categorical phenotype at each center, with all baseline data at a center being included in the analysis. Sex, strain, litter, day of analysis and other experimental metadata (such as the equipment used and certain details of the procedure, such as how blood samples were handled) were included as covariates, and a penalized spline was incorporated to account for systematic changes in the baseline mean over time. Effects from day of analysis and litter were modeled hierarchically with variance components to allow for phenotypic correlation among groups of mice. The posterior evidence for a nonzero mutant genotype effect was summarized and used as a test statistic, and significance thresholds were chosen via a permutation-based approach to control the FDR at 5% for each test at each center (Supplementary Note). The R code to generate the results is available on request.
Phenotype similarity. We used the PhenomeNET 23 system to compute the semantic similarity between the phenotypes observed in EUMODIC and the phenotypes observed with alleles of the same genes in the MGI database. The data from the EUMODIC alleles were excluded from the MGI database for this analysis. To compare sets of phenotypes (either associated with a disease or observed in a mouse model) in PhenomeNET, we used the set-based simGIC semantic similarity measure. simGIC is a Jaccard index weighted with information content and comparing sets closed against the superclass relation. To compute the phenotypic similarity between the phenotypes observed in EUMODIC and those observed with alleles of the same genes in the MGI database, we searched MGI for the unique gene identifier in the EUMODIC data set, excluding all data integrated into MGI from EUMODIC. We tested the null hypothesis that phenotypic similarity between EUMODIC and MGI lines was independent of whether the lines were related to the same or different genes. To do this, for each EUMODIC gene, we ranked all MGI genes according to their phenotypic similarity to that gene, thereby yielding a rank (between 1 and 9,821, i.e., the number of genes in MGI) for each EUMODIC-MGI gene pair. We then performed a Wilcoxon rank-sum test comparing the distribution of ranks for matching EUMODIC-MGI gene pairs against the distribution for non-matching gene pairs.
Analysis of genes with no previous annotations.
A subset of the genes with significant phenotype annotations were classified as having no previous annotation if they had no corresponding alleles in the MGI data set with a curated phenotype from the literature. While performing this analysis, data from this project and the Wellcome Trust Sanger Institute project were incorporated into MGI, so these gene allele combinations now show phenotypic annotations from these projects but remain without annotations from the literature. Two methods were implemented to study this set of 'novel' genes.
npg The first analysis identified human genes orthologous to the mouse genes in Ensembl v76 (ref. 24) . Three data sets (GWAS-central 25 , Orphanet and OMIM) were then mined to search for human diseases associated with these genes 26 . All diseases with associations to these genes were extracted from Orphanet and OMIM. To limit our focus to robust statistical associations in GWAS-central, we extracted data on associations with P < 1 × 10 −5 . To find phenotype correlations between our new mouse phenotypes and human disease, we adopted a phenotype-centric approach. For all the retrieved human data sets, we mapped each phenotypic term to MeSH terms using the US National Institutes of Health MeSH Browser 27 . To find equivalent mouse phenotypes, we manually mapped each higher-level MeSH term to the corresponding higher-level MP ontology term. Previous work has created hierarchical systems to integrate phenotype ontologies across species, but with this data set we found this automated approach problematic and instead adopted a manual process.
Second, in collaboration with experts in the domain and literature, three groups of phenotypic annotations were selected as representative of the three disease areas. The newly annotated genes were placed on the appropriate sections of each Venn diagram depending on the results of the annotation pipeline with respect to these parameters. In total, 94 genes were included in the Venn diagrams.
